The Australian Register of Therapeutic Goods (ARTG) plays a pivotal role in safeguarding the well-being of Australians in the ever-evolving therapeutic goods landscape. Its goal is to ensure that therapeutic products meet the highest safety and quality standards in the country.
If you are venturing into the Australian market as an emerging supplier or a dedicated researcher working on innovative therapeutic solutions, this article is for you. Here, we provide insights into obtaining market authorisation, specifically registering therapeutic goods in Australia.
What Is the Australian Register of Therapeutic Goods?
As briefly outlined above, the Australian Register of Therapeutic Goods (ARTG) is a publicly accessible database that provides valuable information on therapeutic goods available for supply in Australia. There are details about the product name, formulation, sponsor (company), and manufacturer. The Therapeutic Goods Administration (TGA) regulates the ARTG, ensuring that the benefits of therapeutic products outweigh any associated risks for consumers.
The TGA regulates therapeutic goods in Australia through pre-market assessment, post-market monitoring, standards enforcement, and manufacturer licensing. The TGA ensures that therapeutic goods are safe, effective, and of high quality through these regulatory measures.
Steps for Obtaining Market Authorisation and Listing on the ARTG
Understanding regulatory terminology strengthens your preparation process. The Australian Therapeutic Goods Register is the official database that records therapeutic goods approved for lawful supply in Australia. Inclusion in this register confirms that regulatory requirements have been satisfied.
Sponsors must ensure product classification, intended purpose, and risk level are accurately defined before submission. Misclassification can result in delays or formal requests for clarification. Conducting an early compliance and ARTG registration review allows you to identify documentation gaps and confirm that conformity assessment evidence aligns with legislative expectations.
Step 1: Know what therapeutic goods are
Therapeutic goods are essential for promoting and maintaining human health. However, it’s worth noting that not all health-related products are classified as therapeutic goods. Foods and cosmetics, for instance, are generally not considered therapeutic goods.
By clearly defining therapeutic goods, you can ensure that your products meet the specific regulations and requirements of the regulatory authorities.
What are therapeutic goods? Therapeutic goods encompass a range of health-related products used to manage illnesses or injuries, modify bodily processes, perform pregnancy tests, and replace or modify body parts. Here are the main categories of therapeutic goods:
- Medicines – These include complementary medications, over-the-counter medicines, and prescription medicines designed to prevent, treat, or alleviate various health conditions.
- Medical devices – These encompass a diverse range of instruments, implants, and appliances used to diagnose, prevent, monitor, or treat medical conditions.
- Biologicals – These are derived from or contain human cells or tissues for therapeutic purposes.
Step 2: Determine if your product requires an ARTG listing
To establish whether you need to list your medical or dental products on the Australian Register of Therapeutic Goods (ARTG), determine if it falls under the category of therapeutic goods. If your goods are classified as therapeutic, the next step is to explore potential exemptions.
You can find information about exemptions for goods in schedules 5, 5A, or 7 of the Therapeutic Goods Regulations 1990. It’s also essential to verify if any exemptions apply to the sponsor, which you can find in Schedule 8 of the same regulations.
Examples of exempt goods include homeopathic preparations and medicines that practitioners dispense or compound. However, note that there are specific circumstances where therapeutic goods not included in the ARTG can still be lawfully supplied. These products may fall under exempt, excluded, unapproved, or other therapeutic goods.
Step 3: Check if the product is already authorised for supply in Australia
Before proceeding further, you must search the ARTG to see if your product is already available there. If your product is listed, it signifies that it has already received approval from the TGA and has been authorised for distribution in Australia. In this instance, it is advisable to contact the sponsor directly, especially if you intend to become a retail seller.
Step 4: Get a proper understanding of the relevant regulatory guidance
A thorough knowledge of the applicable regulatory guidance is vital to meet market authorisation requirements and fulfil your obligations. Before applying for market authorisation, review the appropriate guidance documents provided by the regulatory authorities.
Strong preparation for ARTG registration begins with confirming the applicable conformity assessment pathway. Sponsors should maintain structured technical documentation that includes risk management reports, clinical evidence where required, and quality management system certification.
Consistency across labelling, instructions for use, and promotional material reduces regulatory risk. Internal document control procedures also help demonstrate traceability during audit or review. Early internal verification strengthens submission accuracy and reduces avoidable assessment delays.
Step 5: Make sure your product meets all relevant requirements
It is important to note that the TGA will only approve your product for supply and grant market authorisation if you fulfil all the relevant legal requirements. So, once you have determined that your therapeutic goods fall within the regulatory framework, ensure that they meet all the applicable legal requirements.
It is your obligation as the sponsor to research the applicable regulatory guidance properly, confirm compliance with the specific standards, and supply the necessary evidence to back up your product’s claims.
Step 6: Apply for market authorisation
The process of applying for market authorisation varies depending on the type and classification of your therapeutic goods and the associated risk level. Market authorisation generally involves three stages:
- Pre-market – Gather the necessary data and information for your therapeutic good, such as clinical trials and scientific evidence, ensuring compliance with regulations.
- Processing – Submit your application through TGA Business Services. The TGA reviews the application for completeness, potentially using automated processes for specific products.
- Post-market – If your product meets the requirements, it receives market authorisation and is included in the ARTG.
The specific details and costs associated with the market authorisation process will vary depending on the nature of your therapeutic goods. For accurate and up-to-date information about your product, consult the relevant regulatory guidance and work with the TGA.
Step 7: Fulfil your post-market responsibilities
Your responsibilities as a sponsor extend beyond the initial market authorisation. It is essential to fulfil ongoing obligations and comply with legal requirements to ensure continued regulatory compliance for your therapeutic goods.
Here are some examples of your post-market responsibilities:
- Information management
- Manufacturing compliance
- Adverse event reporting
- Advertising compliance
Step 8: Register details with TGA
Whether you are a sponsor, manufacturer, or agent involved in the supply of therapeutic goods, it is essential to register your details with the TGA. You should also obtain a Client ID. Doing this establishes a formal presence within the TGA’s regulatory framework. This also allows for efficient communication, access to relevant resources, and the fulfilment of your regulatory obligations as a stakeholder in the supply of therapeutic goods.
Effective compliance planning extends beyond successful registration. Sponsors retain ongoing responsibilities, including adverse event reporting, change notification obligations, and record retention requirements.
Clear post-market procedures support continued regulatory alignment and reduce enforcement risk. Establishing internal accountability frameworks ensures that product updates, manufacturing changes, or safety signals are managed appropriately. Proactive oversight strengthens long term market continuity within Australia.
Common Causes of ARTG Application Delays
You might encounter delays with the Australian therapeutic goods register application process due to incomplete documentation, incorrect product classification, or failure to meet evidence requirements. Misclassifying goods, particularly those combining medical devices and medicines, can require a complete resubmission.
Missing or inconsistent clinical trial results, manufacturing process details, or quality system records often trigger the Therapeutic Goods Administration to request additional information, adding months to approval timelines.
Reduce these risks by confirming your product’s category early, preparing evidence in the format required by the TGA, and ensuring all forms are accurate before submission. Regularly reviewing the latest regulatory updates and guidance documents also helps prevent oversights that could delay approval.
Why Expert Guidance Matters
Managing the Australian therapeutic goods register process requires detailed regulatory knowledge, familiarity with legislative requirements, and precision in document preparation. An experienced medical device consultant can identify compliance gaps, prepare complete and well- structured submissions, and manage direct communication with the TGA. This level of support can shorten approval times, reduce the risk of rejection, and help ensure your post-market obligations are addressed from the start.
For new market entries, this guidance is invaluable in avoiding costly mistakes and building a reliable compliance framework. Working with a consultant also frees you to focus on product development, marketing, and distribution, while knowing your regulatory pathway is managed by someone with proven experience in the Australian therapeutic goods sector.
Key Takeaway
Although therapeutic goods can be very beneficial, they also pose risks. As such, it is imperative to regulate such products to ensure public health.
Businesses in the therapeutic goods industry must comply with the Australian Register of Therapeutic Goods. It ensures these products’ safety, quality, and public health impact. You can navigate the ARTG listing process effectively by following the outlined steps.
Ensure Compliance and Speedy Approvals with Vicki Partridge!
To ensure a smooth compliance journey with the ARTG, seek professional assistance. Vicki Partridge, a highly respected medical device regulatory affairs consultant in Australia, can provide the expertise you need.
Contact Vicki at +61 7 55295508 to discuss how she can assist you with TGA approval and obtaining an ARTG listing for your therapeutic goods.